On November 1, 2022 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), reported that its third quarter 2022 financial results will be released after market close on Tuesday, November 8th, 2022 (Press release, Coherus Biosciences, NOV 1, 2022, View Source/news-releases/news-release-details/coherus-biosciences-report-third-quarter-2022-financial-results" target="_blank" title="View Source/news-releases/news-release-details/coherus-biosciences-report-third-quarter-2022-financial-results" rel="nofollow">View Source [SID1234622712]). Starting at 5:00 p.m. Eastern Time on November 8, 2022, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. The press release with the third quarter 2022 financial results and related materials will be available at View Source prior to the start of the conference call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A replay of the webcast will be available on View Source following the conclusion of the live conference call.